64 results
425
EX-2.1
LAB
Standard BioTools Inc.
4 Oct 23
Business combination disclosure
8:13am
, in violation of Anti-Bribery Laws except, in each case, as would not be material to the Company’s business or operations. Neither the Company nor any … with respect to potential violations of Anti-Bribery Laws except, in each case, as would not be material to the Company’s business or operations. None
8-K
EX-2.1
LAB
Standard BioTools Inc.
4 Oct 23
Standard BioTools and SomaLogic to Combine in All-Stock Merger
8:08am
, in violation of Anti-Bribery Laws except, in each case, as would not be material to the Company’s business or operations. Neither the Company nor any … with respect to potential violations of Anti-Bribery Laws except, in each case, as would not be material to the Company’s business or operations. None
PRE 14A
lar9dn16
11 Feb 22
Preliminary proxy
9:31pm
DEFA14A
5mq5hsu
24 Jan 22
Additional proxy soliciting materials
5:27pm
8-K
EX-10.4
qk56q
24 Jan 22
Fluidigm Announces $250 Million Strategic Capital Infusion from
5:24pm
8-K
EX-10.3
4n5ciy
24 Jan 22
Fluidigm Announces $250 Million Strategic Capital Infusion from
5:24pm